Prot #BTCRC-GI18-149: Phase II Study of the Combination of Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

Project: Research project

Project Details

StatusFinished
Effective start/end date1/21/20 → 1/21/23

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC-GI18-149)
  • Lilly USA, LLC (Prot #BTCRC-GI18-149)